Comparison of the mutation spectrum and association with pre and post treatment lipid measures of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries
- 12 January 2021
- journal article
- research article
- Published by Elsevier BV in Atherosclerosis
- Vol. 319, 108-117
- https://doi.org/10.1016/j.atherosclerosis.2021.01.008
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
- Fondation Leducq
- Fundação para a Ciência e a Tecnologia
- British Heart Foundation
This publication has 41 references indexed in Scilit:
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis SocietyEuropean Heart Journal, 2013
- Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a UK specialist hospital lipid clinicAtherosclerosis, 2013
- Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control studyThe Lancet, 2013
- Description of a Large Family with Autosomal Dominant Hypercholesterolemia Associated with theAPOEp.Leu167del MutationHuman Mutation, 2012
- Familial hypercholesterolaemia: A model of care for AustralasiaAtherosclerosis Supplements, 2011
- Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients: Clinical guidance from the National Lipid Association Expert Panel on Familial HypercholesterolemiaJournal of Clinical Lipidology, 2011
- Founder mutations in the Netherlands: geographical distribution of the most prevalent mutations in the low-density lipoprotein receptor and apolipoprotein B genesNetherlands Heart Journal, 2011
- Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease riskJournal of Medical Genetics, 2006
- Severe Hypercholesterolemia in Four British Families With the D374Y Mutation in the PCSK9 GeneArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Molecular genetics of the LDL receptor gene in familial hypercholesterolemiaHuman Mutation, 1992